Medicskin Holdings Limited Fundamental Analysis (HKSE: 8307.HK)
Medicskin Holdings Limited Fundamental Analysis (HKSE: 8307.HK)
Medicskin Holdings Limited (HKSE: 8307.HK) shows weak financial fundamentals with a PE ratio of 58.36, profit margin of 1.96%, and ROE of 19.79%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 32.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze 8307.HK's fundamental strength across five key dimensions:
Efficiency Score
Weak8307.HK struggles to generate sufficient returns from assets.
Valuation Score
Moderate8307.HK shows balanced valuation metrics.
Growth Score
Moderate8307.HK shows steady but slowing expansion.
Financial Health Score
Weak8307.HK carries high financial risk with limited liquidity.
Profitability Score
Moderate8307.HK maintains healthy but balanced margins.
Key Financial Metrics
Is 8307.HK Expensive or Cheap?
P/E Ratio
8307.HK trades at 58.36 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, 8307.HK's PEG of 0.12 indicates potential undervaluation.
Price to Book
The market values Medicskin Holdings Limited at 10.48 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 4.40 times EBITDA. This is generally considered low.
How Well Does 8307.HK Make Money?
Net Profit Margin
For every $100 in sales, Medicskin Holdings Limited keeps $1.96 as profit after all expenses.
Operating Margin
Core operations generate 17.69 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $19.79 in profit for every $100 of shareholder equity.
ROA
Medicskin Holdings Limited generates $1.83 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Medicskin Holdings Limited produces operating cash flow of $8.57M, showing steady but balanced cash generation.
Free Cash Flow
Medicskin Holdings Limited generates strong free cash flow of $6.66M, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $0.02 in free cash annually.
FCF Yield
8307.HK converts 12.17% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
58.36
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.12
vs 25 benchmark
P/B Ratio
Price to book value ratio
10.48
vs 25 benchmark
P/S Ratio
Price to sales ratio
1.14
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
3.36
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.86
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.20
vs 25 benchmark
ROA
Return on assets percentage
0.02
vs 25 benchmark
ROCE
Return on capital employed
0.83
vs 25 benchmark
How 8307.HK Stacks Against Its Sector Peers
| Metric | 8307.HK Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 58.36 | 31.25 | Worse (Expensive) |
| ROE | 19.79% | 563.00% | Weak |
| Net Margin | 1.96% | 7024.00% | Weak |
| Debt/Equity | 3.36 | 0.51 | Weak (High Leverage) |
| Current Ratio | 0.86 | 5.76 | Weak Liquidity |
| ROA | 1.83% | -63.00% (disorted) | Weak |
8307.HK outperforms its industry in 0 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Medicskin Holdings Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Defensive, Growth, Innovation
EPS CAGR
N/A
Industry Style: Defensive, Growth, Innovation
FCF CAGR
N/A
Industry Style: Defensive, Growth, Innovation